tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bradley Canino, 176 are a BUY (81.86%), 39 are a HOLD (18.14%).
Analyst Bradley Canino, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 34.85% that have a potential upside of 41.25% achieved within 147 days. Previously, Bradley Canino worked at CREDIT SUISSE, STIFEL.
Bradley Canino’s has documented 411 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 30-Aug-2026.
Analyst best performing recommendations are on GLTO (GALECTO).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $25 was fulfilled within 3 days with a profit of $5.86 (30.62%) receiving and performance score of 102.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2022
$4
$1.96 (96.08%)
6 months 26 days ago
(10-Mar-2026)
2/8 (25%)
$1.96 (96.08%)
203
Buy Since 06-Apr-2021
$1
$-0.22 (-18.03%)
$2.2
1 years 4 months 15 days ago
(21-May-2025)
2/6 (33.33%)
$0.59 (143.90%)
235
Hold Since 01-Aug-2024
$1.5
$-0.54 (-26.47%)
$3
1 years 6 months 29 days ago
(07-Mar-2025)
3/8 (37.5%)
$0.44 (41.51%)
324
Buy Since 11-Aug-2020
$21
1 years 7 months ago
(06-Mar-2025)
3/9 (33.33%)
$12.33 (142.21%)
34
Hold Since 06-Mar-2025
$3
$0.96 (47.06%)
1 years 7 months ago
(06-Mar-2025)
1/5 (20%)
$1.69 (129.01%)
93
Which stock is Bradley Canino most bullish on?
Which stock is Bradley Canino most reserved on?
What Year was the first public recommendation made by Bradley Canino?
